SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+6.94%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.32B
AUM Growth
+$1.32B
(-7%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$33.4M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$25.4M |
| 3 |
Alignment Healthcare
ALHC
|
$23.1M |
| 4 |
Vor Biopharma
VOR
|
$23.1M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$21.9M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$38.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$35M |
| 3 |
Labcorp
LH
|
$31.5M |
| 4 |
Exelixis
EXEL
|
$29.6M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Exelixis
EXEL
$9.95B
| $11.1M | 0.84% |
490,058
-1,312,212
| -73% | -$29.6M |
|
52
Guardant Health
GH
$8.11B
| $10.9M | 0.83% |
71,386
-7,600
| -10% | -$1.16M |
|
53
ESSA Pharma
EPIX
$11.2M
| $10.8M | 0.82% |
+371,963
| New | +$10.8M |
|
54
Bolt Biotherapeutics
BOLT
$9.29M
| $10.5M | 0.8% |
+320,010
| New | +$10.5M |
|
55
AbbVie
ABBV
$374B
| $9.9M | 0.75% |
91,500
-3,750
| -4% | -$406K |
|
56
Abbott
ABT
$230B
| $9.55M | 0.72% |
79,698
| – | – |
|
57
Instil Bio
TIL
$196M
| $9.46M | 0.72% |
+377,250
| New | +$9.46M |
|
58
Pulmonx
LUNG
$67.6M
| $9.28M | 0.7% |
+202,900
| New | +$9.28M |
|
59
Molina Healthcare
MOH
$9.6B
| $8.86M | 0.67% |
37,897
-75
| -0.2% | -$17.5K |
|
60
UnitedHealth
UNH
$279B
| $8.8M | 0.67% |
23,650
-1,812
| -7% | -$674K |
|
61
Eli Lilly
LLY
$661B
| $8.73M | 0.66% |
46,715
-4,850
| -9% | -$906K |
|
|
CTLT
62
DELISTED
CATALENT, INC.
CTLT
| $8.24M | 0.62% |
+78,250
| New | +$8.24M |
|
|
FRLN
63
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $8.05M | 0.61% |
654,498
-2,996
| -0.5% | -$36.9K |
|
64
Bristol-Myers Squibb
BMY
$96.7B
| $7.93M | 0.6% |
125,574
-20,000
| -14% | -$1.26M |
|
|
MTEM
65
DELISTED
Molecular Templates, Inc.
MTEM
| $7.78M | 0.59% |
616,450
+391,950
| +175% | +$4.95M |
|
|
SGEN
66
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.28M | 0.55% |
52,406
-5,700
| -10% | -$791K |
|
67
Exact Sciences
EXAS
$9.33B
| $7.25M | 0.55% |
+55,000
| New | +$7.25M |
|
68
MEI Pharma
MEIP
$149M
| $6.73M | 0.51% |
+1,961,667
| New | +$6.73M |
|
69
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.61M | 0.5% |
87,472
-9,300
| -10% | -$702K |
|
|
CMPI
70
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $6.58M | 0.5% |
541,766
-7,036
| -1% | -$85.4K |
|
71
Cigna
CI
$80.2B
| $6.36M | 0.48% |
26,297
-1,444
| -5% | -$349K |
|
|
FNCH
72
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $6.3M | 0.48% |
+390,000
| New | +$6.3M |
|
73
Medtronic
MDT
$118B
| $6.2M | 0.47% |
52,501
+14,000
| +36% | +$1.65M |
|
|
VIRX
74
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $5.99M | 0.45% |
+647,556
| New | +$5.99M |
|
|
NCNA
75
NuCana
NCNA
$5.8M
| $5.56M | 0.42% |
1,114,801
+364,801
| +49% | +$1.82M |
|